In parallel, we analyzed the surface levels of ROR1 (and CCR7, the receptor for CCL19, as a control) in the non-migratory (upper chamber) and migratory (lower chamber) CLL cells (for schematics see Figure 5A). This evidence concerns the gene ROR1 and B-cell chronic lymphocytic leukemia.